TSWM
Triangle Securities Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $769K | Buy |
1,728
+10
| +0.6% | +$4.45K | 0.19% | 120 |
|
|
2025
Q1 | $833K | Sell |
1,718
-48
| -3% | -$23.3K | 0.21% | 117 |
|
|
2024
Q4 | $711K | Sell |
1,766
-19
| -1% | -$7.65K | 0.18% | 129 |
|
|
2024
Q3 | $830K | Sell |
1,785
-45
| -2% | -$20.9K | 0.21% | 121 |
|
|
2024
Q2 | $858K | Sell |
1,830
-20
| -1% | -$9.37K | 0.24% | 114 |
|
|
2024
Q1 | $773K | Sell |
1,850
-43
| -2% | -$18K | 0.22% | 119 |
|
|
2023
Q4 | $770K | Sell |
1,893
-98
| -5% | -$39.9K | 0.24% | 113 |
|
|
2023
Q3 | $692K | Sell |
1,991
-159
| -7% | -$55.3K | 0.25% | 110 |
|
|
2023
Q2 | $757K | Sell |
2,150
-200
| -9% | -$70.4K | 0.26% | 111 |
|
|
2023
Q1 | $740K | Sell |
2,350
-58
| -2% | -$18.3K | 0.26% | 110 |
|
|
2022
Q4 | $695K | Sell |
2,408
-450
| -16% | -$130K | 0.25% | 113 |
|
|
2022
Q3 | $828K | Sell |
2,858
-205
| -7% | -$59.4K | 0.34% | 85 |
|
|
2022
Q2 | $863K | Buy |
3,063
+173
| +6% | +$48.7K | 0.34% | 89 |
|
|
2022
Q1 | $754K | Sell |
2,890
-258
| -8% | -$67.3K | 0.25% | 110 |
|
|
2021
Q4 | $691K | Buy |
3,148
+135
| +4% | +$29.6K | 0.22% | 118 |
|
|
2021
Q3 | $547K | Buy |
3,013
+425
| +16% | +$77.2K | 0.19% | 127 |
|
|
2021
Q2 | $522K | Buy |
+2,588
| New | +$522K | 0.18% | 128 |
|
|
2013
Q3 | – | Sell |
-850
| Closed | -$68K | – | 378 |
|
|
2013
Q2 | $68K | Buy |
+850
| New | +$68K | 0.05% | 218 |
|